O96133 AF NFT

Repetitive organellar protein

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidoyz73adjcnpnnbkex7ypbmyi3bvcslfbpielgeucvsjyrdcd55a/metadata.json
IPFS of structure file: 
bafybeiepieunzfftxapsdgigirxiavaz4yhaf32wkzptwi6goro54crviu/AF-O96133-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x80c65687F966a6264124948aC6721671E4B4d776
First NFT owner address (bech32): 
genesis1srr9dplev6nzvsfyjj9vvuskw8jtf4mkhynhfg
Current NFT ID #384655 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
384655
Accession (UniProt):
O96133
Name::
Repetitive organellar protein
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O96133 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O96133|ROPE_PLAF7 Repetitive organellar protein OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=ROPE PE=1 SV=1 MVFTFKNKKKKKEASSDKVSKESFNEEDNENNEKREKSDSWYKKIIETKGKSKTKYKNDNSLDDNINEDIINNNNNNNNDNNNDNNNDNNNDNNNDNNNDNNNENNNDNNNFNNYSDEISKNIIHKDNELENQLKDTLKSISSLSNKIVNYESKIEELEKELKEVKDKNIDNNDYENKLKEKEDFVKQKIDMLNEKENLLQEKELDINKREKKINEKEKNIIKKEETFHNIEKEYLEKNKERETISIEIIDIKKHLEKLKIEIKEKKEDLENLNKKLLSKENVLKELKGCVKEKNETINSLNDNIIEKEKKYKLLEYELEEKNKQIDLLNKQEKEKEKEKEREKEKEREKEKEKEYDTLIKELKDEKISILEKVHSIKVREMDIEKREHNFLHMEDQLKDLKNSFVKNNNQLKVYKCEIKNLKTELEKKEKELKDIENVSKEEINKLINQLNEKEKQILAFNKNHKEEIHGLKEELKESVKITKIETQELQEMVDIKQKELDQLQEKYNAQIESISIELSKKEKEYNQYKNTYIEEINNLNEKLEETNKEYTNLQNNYTNEINMLNNDIHMLNGNIKTMNTQISTLKNDVHLLNEQIDKLNNEKGTLNSKISELNVQIMDLKEEKDFLNNQIVDLSNQIDLLTRKMEEKENKMLEQENKYKQEMELLRGNIKSSENILNNDEEVCDLKRKLSLKESEMKMMKEEHDKKLAELKDDCDVRIREMNEKNEDKINMLKEEYEDKINTLKEQNEDKINTLKEQNEDKINTLKEEYEHKINTMKEEYEHKINTLNEQNEHKINTLNEQNEHKINTMKEEYEDKMNTLNEQNEDKMNSLKEEYENKINQINSNNEIKIKDVVNEYIEEVDKLKVTLDEKKKQFDKEINYAHIKAHEKEQILLTEMEELKCQRDNKYSDLYEKYIKLIKSICMIINIECCDDIENEDIIRRIEEYINNNKGLKKEVEEKEHKRHSSFNILKSKEKFFKNSIEDKSHELKKKHEKDLLSKDKEIEEKNKKIKELNNDIKKLQDEILVYKKQSNAQQVDHKKKSWILLKDKSKEKIKDKENQINVEKNEEKDLKKKDDEIRILNEELVKYKTILYNLKKDPLLQNQDLLSKIDINSLTINEGMCVDKIEEHILDYDEEINKSRSNLFQLKNEICSLTTEVMELNNKKNELIEENNKLNLVDQGKKKLKKDVEKQKKEIEKLNKQLTKCNKQIDELNEEVEKLNNENIELITYSNDLNNKFDMKENNLMMKLDENEDNIKKMKSKIDDMEKEIKYREDEKKRNLNEINNLKKKNEDMCIKYNEMNIKYGDICVKYEEMSLTYKETSLKYEQIKVKYDEKCSQYDEIRFQYDEKCFQYDEINKKYGALLNINITNKMVDSKVDRNNNEIISVDNKVEGIANYLKQIFELNEEIIRLKGEINKISLLYSNELNEKNSYDINMKHIQEQLLFLEKTNKENEEKIINLTSQYSDAYKKKSDESKLCGAQFVDDVNIYGNISNNNIRTNEYKYEEMFDTNIEEKNGMHLSKYIHLLEENKFRCMKIIYENENIKSSNKIIGLYNYSRYYGLREDLCKEEIVPSKIGNISNKNENNNKKNNTCDGYDEKVTIVLCIILNEIIKFLFLNDEYVLLFEKIHKNVWKRMYIPEEIKFFILKYITLLNNLRDYIISVHNNMKNEKYDECWFLFQHYFERSSDVRKEMVHFLLERKSQENLISFKSKLKSKKEKILTMDILNFSKEHMQLKTIAHLRKEINYEKLSKDTLNRDYNLLLYKYQECVSKLKRVKNLMKEINQNVFIEKYDDISKELDNFSDGYNEQNEQHVMDPILLNNNKNKNNKLITEHNNPIINRLTNFTQNRDSKYKNKIMDDVKQRKINSTMNNTNKNGINIIYNHYENLNKPNYNDNINRLNSYHQNIHIANSIHPNRNQNKSFLTNQANSTYSVMKNYINSDKPNLNGKKSVRNIFNEIVDENVNKTFVHKSVFF